NKGN NKGen Biotech Kompaniya foydasi

Alzheimer kasalligi terapiyasi bo'yicha klinik sinovlar natijalariga bo'lgan kutish NKGen Biotech, Inc. (NKGN) uchun asosiy turtki vazifasini o'taydi. Kompaniyaning sof foydasi Fed siyosati qat'iy bo'lgan davrdagi moliyaviy dinamikani aks ettiradi, bunda 0.00 ushbu ko'rsatkichning darajasini ko'rsatadi. O'sish NK-hujayralar tadqiqotlari bo'yicha tibbiyot markazlari bilan hamkorlikka va hujayra mahsulotlarini kengaytirishda xarajatlarni kamaytirish uchun AI bioreaktorlarini joriy etishga bog'liq.

NKGen (NKGN) Sof foyda: 21.02.2024 - 15.03.2025 davri uchun

NKGen Biotech (NKGN) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi NKGen Biotech Corp|NKGN - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi NKGen Biotech Corp|NKGN - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi haqida ma'lumot:
Bitta aksiya hisobiga balans qiymati NKGen Biotech|NKGN - Balans kapitallashuvi|Bozor qiymatining xususiy kapitalga nisbati nkgenbiotech.com|NKGN - Kompaniyaning umumiy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Qarzning kapitalga nisbati NKGen Biotech, Inc.|NKGN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi NKGen Biotech Inc|NKGN - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati NKGen Biotech Corp|NKGN - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi NKGen Biotech|Oraliq qoplama koeffitsiyenti nkgenbiotech.com
- foyda va bozor multiplikatorlari tafsilotlari:
NKGN - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:NKGen Biotech Corp (NKGN)

Fundamental jihatdan barqaror aktivlarni tanlash uchun investorlarga biznesning haqiqiy tijorat qiymatini yaratish qobiliyatini baholash juda muhimdir. Ushbu ko'rsatkich kunlik sof daromad tendentsiyalarini umumlashtirib, kompaniyaning moliyaviy natijalari bozor shovqinlarini filtrlashiga va NKGen Biotech (NKGN) neyrodegenerativ kasalliklar uchun daromad keltirmaydigan hujayra terapiyasi segmentida duch kelayotgan shiddatli raqobat sharoitida kapitalni boshqarish samaradorligini ochib berishiga imkon beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|Kompaniya foydasi RGC (regencellbioscience.com)|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|Sof foyda ACADIA Pharma (ACAD)|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Yillik sof foyda Viking Therapeutics Corp|Supernus Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi catalystpharma.com|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Kompaniya foydasi HRMY|Sof daromad BHVN|AMLX: Yakuniy foyda|Sof foyda TRVI|Kompaniyaning sof foydasi PRAX (praxismedicines.com)|Sof foyda AVXL (Anavex Life Sciences Corp.)|Sof moliyaviy natija CeriBell Inc (CBLL)|PRTA - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Alector, Inc.|ANNX (Annexon, Inc.) - Sof daromad|OMER: Soliqlar to‘langandan keyingi foyda|NGNE (Neurogene) - Sof foyda|Kompaniyaning sof daromadi AC Immune S.A. ACIU|Sof foyda VYGR|Sof daromad Neumora Corp NMRA|Sof foyda SCLX (Scilex Holding Company)|Yakuniy foyda TVGN|ACOG: Sof daromad|Yakuniy foyda CGTX (cogrx.com)|IKT: Sof foyda|SAVA - Sof moliyaviy natija|Kompaniyaning sof foydasi Assertio Holdings|Kompaniya foydasi COYA (Coya)|Sof foyda VTGN|Sof daromad ovidrx.com OVID|Acumen Pharma - Sof daromad|Sof moliyaviy natija CervoMed Corporation (CRVO)|ATHE - Kompaniyaning sof foydasi|CLNN (Clene Inc.) - Kompaniya foydasi|pepgen.com (PEPG) - Kompaniyaning sof foydasi|jupiterneurosciences.com (JUNS) - Sof foyda|RLMD (Relmada) - Sof foyda|ANVS - Yillik sof foyda|Kompaniyaning sof foydasi Grace Therapeutics, Inc. (GRCE)|fireflyneuro.com - Kompaniya foydasi|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|NRSN: Kompaniya foydasi|Reviva Pharmaceuticals Holdings - Sof foyda|Kompaniyaning sof daromadi MetaVia Inc|NRXS (NeurAxis, Inc.) - Sof daromad|Helius Medical Technologies (HSDT) - Sof foyda|Kompaniyaning sof foydasi Passage Bio Inc.|NEUP: Yakuniy foyda|Kompaniyaning sof foydasi Minerva Neurosciences Corp (NERV)|ATHA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Addex Therapeutics ADXN|ALZN: Kompaniya foydasi|CYCN - Kompaniyaning sof foydasi|PTIX - Sof foyda|KTTA: Sof foyda|Yillik sof foyda Cortigent CRGT|ATXI (Avenue Therapeutics) - Sof foyda|Kompaniyaning sof daromadi brainstorm-cell.com BCLI|Kompaniyaning sof foydasi Cara Therapeutics (CARA)|Chromocell Therapeutics Corp - Kompaniya foydasi|Eliem Therapeutics Inc. - Sof daromad|Yakuniy foyda ITCI|Longboard Pharmaceuticals - Sof foyda|MRNS: Kompaniyaning sof foydasi|NRBO: Sof foyda|SAGE - Sof moliyaviy natija|Kompaniyaning sof foydasi Neurotrope|Kompaniyaning sof daromadi Trevena Inc TRVN|Sof daromad VIGL (Vigil Neuroscience)|Soliqlar to‘langandan keyingi foyda WENA|Sof foyda CERE (Cerevel Therapeutics, Inc.)